Published
- Adults
- Households
- Travelers
- Patients with immune suppression
Prepared · sources accessed (UTC) · physician review still to be recorded
Infection-related care often involves more than a single test. A screening result may need confirmation, a positive result may require treatment and monitoring, and a vaccine recommendation may depend on records that are spread across several systems. The practical question is what needs to happen after today’s visit.
This guide helps you organize prevention, testing, and follow-up without treating every infection as the same problem. It connects the existing guides to adult vaccines, respiratory infections, and medication safety during travel.
Prepare a vaccination visit when guidance has changed
Bring available vaccine records, previous reactions, relevant medical conditions, current medicines, and any upcoming travel or treatment. Ask which recommendations apply to you today and what source and date the clinician is using. Missing documentation and a documented incomplete series are different situations and may require different follow-up.
California’s CDPH vaccine guidance page links current state recommendations and explains that guidance is updated. This guide does not reproduce a seasonal schedule or assume federal, state, professional-society, and coverage rules always say exactly the same thing.
Separate clinical suitability from practical access. Confirm the product, where it can be given, coverage or cost, and whether another dose or record update is needed. Ask the vaccinating service to provide a record you can share with your usual clinician. Do not rely solely on recollection of a brand name or a past appointment.
Follow hepatitis screening through confirmation and care
Hepatitis B and hepatitis C testing answer different questions and use different markers. Ask for the actual test names rather than only a message saying “hepatitis positive.”
CDC explains that hepatitis B markers are interpreted together to distinguish infection, susceptibility, and patterns of immunity. Its hepatitis B testing guidance describes the triple-panel approach and the need for appropriate interpretation.
For hepatitis C, a reactive antibody result can reflect past or current infection; RNA testing determines whether virus is currently detected. CDC recommends automatic follow-up RNA testing after a reactive antibody result, but a patient should still confirm that the result was obtained and explained. See CDC’s hepatitis C diagnostic guidance.
If ongoing care is needed, identify the clinician, first appointment, relevant additional evaluation, and barriers to treatment access. A referral or prescription request does not mean treatment has started. Keep confirmation, treatment initiation, and later monitoring as separate milestones.
Match HIV and STI testing to the exposure and timing
Tell the clinician which concern prompted testing, when it occurred, and which symptoms are present. Ask which infections and body sites the ordered tests address; a generic “STI panel” does not necessarily answer every exposure-related question. CDC explains why testing choices can include different specimens and body sites in its STI testing guide.
CDC explains that HIV tests have different detection windows and that an early negative result may require repeat testing. A positive antibody screening test requires follow-up confirmation. See CDC’s HIV testing guide. Ask for the repeat date or confirmation plan in writing instead of deciding that one early result settles the matter.
Discuss how results will be delivered, what treatment or partner-related steps may be needed, and how privacy is handled in the actual service. Do not assume a portal message, insurance communication, or shared telephone is private.
Possible recent HIV exposure needs immediate clinical assessment. When post-exposure prophylaxis, or PEP, is indicated, CDC recommends starting it as soon as possible, ideally within 24 hours and no later than 72 hours after exposure. If your usual clinic cannot see you today, go to an emergency department or urgent care now. Do not wait for symptoms or a routine testing appointment. If more time has passed, still seek assessment for testing, follow-up, and prevention advice. See CDC’s PEP guidance.
Understand inactive TB versus active disease
A positive TB blood or skin test requires medical evaluation to distinguish inactive infection from active disease. CDC describes the role of history, examination, imaging, and other testing. People with inactive TB do not have symptoms from active disease and do not spread TB, while active disease can require urgent treatment and public-health coordination. See CDC’s TB diagnosis guide.
Ask what has been established and which result is still pending. If you have symptoms or a known exposure, tell the clinic before arriving so it can give appropriate instructions. Do not decide whether you are infectious from the screening result alone.
If treatment is recommended, clarify the plan, monitoring, possible side effects to report, and what to do if a dose or appointment is missed. Keep a copy of testing and treatment records for future care, work, school, or other documentation needs. A completed course should be documented by the treating service rather than inferred from an empty medicine container.
Give persistent symptoms their own assessment
After an infection, describe what has improved and what remains: fatigue, breathlessness, difficulty concentrating, pain, sleep disruption, or another problem. Include the effect on ordinary activities and whether symptoms worsen after physical or mental effort.
CDC describes a wide range of possible Long COVID symptoms and emphasizes assessment and symptom-focused care. It notes that there is no single laboratory test that establishes whether symptoms are due to Long COVID. See CDC’s symptoms resource.
Do not assume every new symptom is an expected part of recovery or that a normal routine test means the symptoms are unreal. Ask what other causes need consideration and what changes require earlier review. If exertion causes delayed worsening, report it before following a generic exercise progression. The aim is an individual recovery plan, not forcing the same timetable on every person.
Plan travel around continuity of essential care
Bring your itinerary, including remote destinations and activities, to a pre-travel discussion. Ask about destination-specific prevention, existing conditions, medicine supply, storage, and what to do if treatment is interrupted. The relevant advice can change with travel dates and health circumstances.
CDC’s Pack Smart guidance recommends preparing essential health documents and medicines and checking destination restrictions. A medicine legally prescribed at home is not automatically permitted in every country. Verify requirements with official destination authorities rather than relying only on a general packing list.
Carry a current medication and allergy summary and know how to contact care at home and at the destination. Use the trip-document and contingency guide for broader travel preparation and outbreak-report interpretation for distinguishing a news report from an individual travel recommendation.
Fictional worked example: a reactive result with one missing step
Luis, 48, sees “reactive” beside a hepatitis C antibody result. He feels well and assumes the result either proves current infection or must be a mistake. No RNA result is visible.
Luis contacts the ordering team and asks whether follow-up RNA testing was performed. The team checks the laboratory workflow, arranges the missing step if needed, and sets a date to explain the completed results. If care is required, they identify the receiving clinician and an access contact.
The example does not predict Luis’s final diagnosis. Its point is that an initial screening marker and evidence of current infection are different pieces of information, and the missing step needs explicit follow-through.
Printable infection-care follow-through sheet
Use one sheet for each clinical question. Keep personal results private and share them through your treating service’s approved channel.
| Field | My entry |
|---|---|
| Reason for visit: prevention, exposure, symptoms, or screening | ______ |
| Relevant dates, vaccine records, and medicines | ______ |
| Exact test name and specimen date | ______ |
| Result and clinician’s interpretation | ______ |
| Confirmation or repeat test still needed | ______ |
| Treatment / prevention plan and responsible team | ______ |
| Symptoms or side effects requiring earlier contact | ______ |
| Access obstacle and person helping resolve it | ______ |
| Completion or review date | ______ |
For an unresolved result, use results and referral follow-through. For work or environmental exposure details, use the exposure-history guide.
Questions readers ask
Does a positive antibody test always mean an active infection?
No. The meaning depends on the infection, the test, timing, and other results. Ask which marker was measured and what confirmation or interpretation is required. Do not generalize one infection’s testing rules to another.
Can an early negative test rule out a recent exposure?
Not always. Detection windows and the type of test matter. Ask the clinician whether repeat testing or a time-sensitive preventive assessment is needed, and record the agreed timing.
Should I keep treatment records after I feel better?
Yes. A dated summary helps future clinicians understand what was diagnosed, treated, and confirmed. Feeling better is useful information, but it does not replace any required follow-up or documentation.
Sources and scope
Primary sources: CDPH vaccines; CDC on hepatitis B, hepatitis C, HIV testing, STI testing, PEP, TB diagnosis, Long COVID, and travel preparation.
Prepared November 5, 2026, Pacific. human clinical review pending. Exposure management, vaccine suitability, infectiousness, immune-suppression decisions, and treatment require individual, current clinical advice. No specific seasonal schedule or drug regimen is prescribed here.